CoChat

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

Open access
Allen, Mariet, Kachadoorian, Michaela, Quicksall, Zachary, Zou, Fanggeng, Chai, High Seng, Younkin, Curtis, Crook, Julia E, Pankratz, V Shane, Carrasquillo, Minerva M, Krishnan, Siddharth, Nguyen, Thuy, Ma, Li, Malphrus, Kimberly, Lincoln, Sarah, Bisceglio, Gina, Kolbert, Christopher P, Jen, Jin, Mukherjee, Shubhabrata, Kauwe, John K, Crane, Paul K, Haines, Jonathan L, Mayeux, Richard, Pericak-Vance, Margaret A, Farrer, Lindsay A, Schellenberg, Gerard D, Alzheimer’s Disease Genetics Consortium (ADGC), Parisi, Joseph E, Petersen, Ronald C, Graff-Radford, Neill R, Dickson, Dennis W, Younkin, Steven G, Ertekin-Taner, Nilüfer · 2014 · Alzheimer's Research & Therapy
Cited by 154

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Introduction: MAPT encodes for tau, the predominant component of neurofibrillary tangles that are neuropathological hallmarks of Alzheimer’s disease (AD). Genetic association of MAPT variants with late-onset AD (LOAD) risk has been inconsistent, although insufficient power and incomplete assessment of MAPT haplotypes may account for this. Methods: We examined the association of MAPT haplotypes with LOAD risk in more than 20,000 subjects (n-cases = 9,814, n-controls = 11,550) from Mayo Clinic (n-cases = 2,052, n-controls = 3,406) and the Alzheimer’s Disease Genetics Consortium (ADGC, n-cases = 7,762, n-controls = 8,144). We also assessed associations with brain MAPT gene expression levels measured in the cerebellum (n = 197) and temporal cortex (n = 202) of LOAD subjects. Six single nucleotide polymorphisms (SNPs) which tag MAPT haplotypes with frequencies greater than 1% were evaluated. Results: H2-haplotype tagging rs8070723-G allele associated with reduced risk of LOAD (odds ratio, OR = 0.90, 95% confidence interval, CI = 0.85-0.95, p = 5.2E-05) with consistent results in the Mayo (OR = 0.81, p = 7.0E-04) and ADGC (OR = 0.89, p = 1.26E-04) cohorts. rs3785883-A allele was also nominally significantly associated with LOAD risk (OR = 1.06, 95% CI = 1.01-1.13, p = 0.034). Haplotype analysis revealed significant global association with LOAD risk in the combined cohort (p = 0.033), with significant association of the H2 haplotype with reduced risk of LOAD as expected (p = 1.53E-04) and suggestive association with additional haplotypes. MAPT SNPs and haplotypes also associated with brain MAPT levels in the cerebellum and temporal cortex of AD subjects with the strongest associations observed for the H2 haplotype and reduced brain MAPT levels (β = -0.16 to -0.20, p = 1.0E-03 to 3.0E-03). Conclusions: These results confirm the previously reported MAPT H2 associations with LOAD risk in two large series, that this haplotype has the strongest effect on brain MAPT expression amongst those tested and identify additional haplotypes with suggestive associations, which require replication in independent series. These biologically congruent results provide compelling evidence to screen the MAPT region for regulatory variants which confer LOAD risk by influencing its brain gene expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/alzrt268

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Principal components analysis corrects for stratification in genome-wide association studies

    Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 1×

    “obtained from EIGENSTRAT [32].”
  • Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

    (EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 1×

    “0E-7 in the recent meta-analysis of 74,046 individuals by the IGAP consortium [39].”
    BackgroundSelf-citation
  • Robust relationship inference in genome-wide association studies

    Manichaikul, A., Mychaleckyj, J. C., Rich, S. S., Daly, K., Sale, M., & Chen, W.-M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq559 · Cited by 3,541 · cited 3×

    “The genotypes for these six SNPs were extracted from the ADGC GWAS data [27] using PLINK [31].”
    Method
  • Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

    Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 2×

    “Rare missense and exon 10 splicing mutations, which lead to increased levels of tau isoforms with four microtubule binding domains (aka 4-repeat or 4R tau) lead to familial frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) [2,3], whereas the common MAPT H1 haplotype strongly associates with i…”
    BackgroundSelf-citation
  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

    Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 2×

    “All cohort genotypes were imputed to a common set of >2 million SNPs (HapMap2) by the ADGC, as described [26].”
    BackgroundMethodSelf-citation
  • Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

    Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · cited 2×

    “Rare missense and exon 10 splicing mutations, which lead to increased levels of tau isoforms with four microtubule binding domains (aka 4-repeat or 4R tau) lead to familial frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) [2,3], whereas the common MAPT H1 haplotype strongly associates with i…”
    Background
  • Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy

    Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781 · cited 3×

    “Rare missense and exon 10 splicing mutations, which lead to increased levels of tau isoforms with four microtubule binding domains (aka 4-repeat or 4R tau) lead to familial frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) [2,3], whereas the common MAPT H1 haplotype strongly associates with i…”
    BackgroundSelf-citation
  • Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

    Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering–Brown, S., Adamson, J., Lees, A. J., Rossor, M. N., Quinn, N. P., Kertesz, A., et al. (2001) · Neurology · doi:10.1212/wnl.56.12.1702 · Cited by 409 · cited 3×

    “Rare missense and exon 10 splicing mutations, which lead to increased levels of tau isoforms with four microtubule binding domains (aka 4-repeat or 4R tau) lead to familial frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) [2,3], whereas the common MAPT H1 haplotype strongly associates with i…”
    BackgroundSelf-citation
  • Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer’s disease

    Carrasquillo, M. M., Zou, F., Pankratz, V. S., Wilcox, S. L., Ma, L., Walker, L. P., Younkin, S. G., Younkin, C. S., Younkin, L. H., Bisceglio, G. D., et al. (2009) · Nature Genetics · doi:10.1038/ng.305 · Cited by 296 · cited 11×

    “Aβ: Amyloid-beta; AD: Alzheimer’s disease; ADGC: Alzheimer’s disease genetics consortium; CBD: Corticobasal degeneration; CSF: Cerebrospinal fluid; CER: Cerebellum; eGWAS: Gene expression genome-wide association study; GWAS: Genome-wide association study; HWE: Hardy-Weinberg equilibrium; ICC: Intraclass coefficient; J…”
    MethodInfluentialSelf-citation
  • Cis -acting expression quantitative trait loci in mice

    Doss, S., Schadt, E. E., Drake, T. A., & Lusis, A. J. (2005) · Genome Research · doi:10.1101/gr.3216905 · Cited by 273 · cited 1×

    “We previously annotated all our probes for variants in their sequence [22], given the concern that such variants may result in differential binding of probes with artifactual variance in the expression levels, and therefore could result in false positive associations with genetic variants in LD with probe sequence var…”
    Background

Show all 12 references

Cited by

Metadata

Authors
Allen, M., Kachadoorian, M., Quicksall, Z., Zou, F., Chai, H. S., Younkin, C., Crook, J. E., Pankratz, V. S., Carrasquillo, M. M., Krishnan, S., Nguyen, T., Ma, L., Malphrus, K., Lincoln, S., Bisceglio, G., Kolbert, C. P., Jen, J., Mukherjee, S., Kauwe, J. K., Crane, P. K., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Farrer, L. A., Schellenberg, G. D., Alzheimer’s Disease Genetics Consortium (ADGC), Parisi, J. E., Petersen, R. C., Graff-Radford, N. R., Dickson, D. W., Younkin, S. G., & Ertekin-Taner, N.
Venue
Alzheimer's Research & Therapy
Published
2014-07-01
Volume
6
Issue
4
Pages
39-39
ISSN
1758-9193 (ISSN-L)
OpenAlex
W1963919142
Cited by
154
References
12
FWCI
7.19
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.